Drug Shortage Report for TEVA-ESOMEPRAZOLE
| Report ID | 104339 |
| Drug Identification Number | 02423863 |
| Brand name | TEVA-ESOMEPRAZOLE |
| Common or Proper name | ESOMEPRAZOLE 40MG OG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 30UD |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-01-22 |
| Estimated end date | 2021-03-31 |
| Actual end date | 2021-03-10 |
| Shortage status | Resolved |
| Updated date | 2021-03-11 |
| Company comments | Allocating until re-supply |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.